The etiology and pathogenesis of Alzheimer's disease (AD) remains unknown. Although important advances have been made in the past year and a half towards characterizing molecular genetic processes which may underlie the development of this disorder, it is likely that a combination of both genetic and environmental factors is involved. A potential environmental factor implicated in the pathogenesis of AD is the neurotoxicity of aluminum. For the past ten years our laboratory has provided the principal scientific data upon which aluminum is linked, to the pathogenesis of AD. Using tissue microprobe approaches, we have demonstrated the presence of selective accumulation of aluminum in neurofibrillary tangle-bearing neurons, a major neuropathologic feature of AD. In the proposed study we will evaluate whether aluminum accumulation is confined solely to the neurofibrillary tangle-bearing neurons or whether trace elemental abnormalities are encountered in association with the other forms of cytopathology seen in the brains of AD victims, namely senile plaques, granulovacuolar degeneration, Hirano bodies, and vascular amyloid deposition. For this study we will employ laser microprobe mass analysis, an extremely sensitive arid precise technique for defining trace elemental content and distribution within tissue specimens. We will, in addition, investigate the nature of the aluminum accumulations seen in association with neurofibrillary tangles by evaluating the trace elemental content of extracellular """"""""ghost"""""""" tangles and a hippocampal cell population resistant to neurofibrillary tangle formation, namely the neurons of the H2 region. By studying non-CNS organs known to accumulate aluminum, we will evaluate if excessive systemic aluminum exposure to the element has occurred. By expanding our knowledge of the composition, location and association of these trace elemental abnormalities with the various forms of cytopathology seen in AD we can begin to appreciate their nature and consequences.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
2P50AG005138-06
Application #
3813965
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Type
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10029
Barnes, Josephine; Bartlett, Jonathan W; Wolk, David A et al. (2018) Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease. J Alzheimers Dis 64:631-642
Gandal, Michael J; Haney, Jillian R; Parikshak, Neelroop N et al. (2018) Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science 359:693-697
Huckins, L M; Hatzikotoulas, K; Southam, L et al. (2018) Investigation of common, low-frequency and rare genome-wide variation in anorexia nervosa. Mol Psychiatry 23:1169-1180
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416
Ki?emet-Piska?, Spomenka; Babi? Leko, Mirjana; Blažekovi?, Antonela et al. (2018) Evaluation of cerebrospinal fluid phosphorylated tau231 as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia. CNS Neurosci Ther 24:734-740
Soleimani, Laili; Ravona-Springer, Ramit; Heymann, Anthony et al. (2018) Depression is more strongly associated with cognition in elderly women than men with type 2 diabetes. Int Psychogeriatr :1-5
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Audrain, Mickael; Haure-Mirande, Jean-Vianney; Wang, Minghui et al. (2018) Integrative approach to sporadic Alzheimer's disease: deficiency of TYROBP in a tauopathy mouse model reduces C1q and normalizes clinical phenotype while increasing spread and state of phosphorylation of tau. Mol Psychiatry :
Boban, Mirta; Babi? Leko, Mirjana; Miški?, Terezija et al. (2018) Human neuroblastoma SH-SY5Y cells treated with okadaic acid express phosphorylated high molecular weight tau-immunoreactive protein species. J Neurosci Methods :
Zhu, Carolyn W; Grossman, Hillel; Neugroschl, Judith et al. (2018) A randomized, double-blind, placebo-controlled trial of resveratrol with glucose and malate (RGM) to slow the progression of Alzheimer's disease: A pilot study. Alzheimers Dement (N Y) 4:609-616

Showing the most recent 10 out of 555 publications